Cargando…

Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities

Breeding has been used successfully for many years in the fruit industry, giving rise to most of today’s commercial fruit cultivars. More recently, new molecular breeding techniques have addressed some of the constraints of conventional breeding. However, the development and commercial introduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobato-Gómez, Maria, Hewitt, Seanna, Capell, Teresa, Christou, Paul, Dhingra, Amit, Girón-Calva, Patricia Sarai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286259/
https://www.ncbi.nlm.nih.gov/pubmed/34274949
http://dx.doi.org/10.1038/s41438-021-00601-3
_version_ 1783723709389864960
author Lobato-Gómez, Maria
Hewitt, Seanna
Capell, Teresa
Christou, Paul
Dhingra, Amit
Girón-Calva, Patricia Sarai
author_facet Lobato-Gómez, Maria
Hewitt, Seanna
Capell, Teresa
Christou, Paul
Dhingra, Amit
Girón-Calva, Patricia Sarai
author_sort Lobato-Gómez, Maria
collection PubMed
description Breeding has been used successfully for many years in the fruit industry, giving rise to most of today’s commercial fruit cultivars. More recently, new molecular breeding techniques have addressed some of the constraints of conventional breeding. However, the development and commercial introduction of such novel fruits has been slow and limited with only five genetically engineered fruits currently produced as commercial varieties—virus-resistant papaya and squash were commercialized 25 years ago, whereas insect-resistant eggplant, non-browning apple, and pink-fleshed pineapple have been approved for commercialization within the last 6 years and production continues to increase every year. Advances in molecular genetics, particularly the new wave of genome editing technologies, provide opportunities to develop new fruit cultivars more rapidly. Our review, emphasizes the socioeconomic impact of current commercial fruit cultivars developed by genetic engineering and the potential impact of genome editing on the development of improved cultivars at an accelerated rate.
format Online
Article
Text
id pubmed-8286259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82862592021-07-23 Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities Lobato-Gómez, Maria Hewitt, Seanna Capell, Teresa Christou, Paul Dhingra, Amit Girón-Calva, Patricia Sarai Hortic Res Review Article Breeding has been used successfully for many years in the fruit industry, giving rise to most of today’s commercial fruit cultivars. More recently, new molecular breeding techniques have addressed some of the constraints of conventional breeding. However, the development and commercial introduction of such novel fruits has been slow and limited with only five genetically engineered fruits currently produced as commercial varieties—virus-resistant papaya and squash were commercialized 25 years ago, whereas insect-resistant eggplant, non-browning apple, and pink-fleshed pineapple have been approved for commercialization within the last 6 years and production continues to increase every year. Advances in molecular genetics, particularly the new wave of genome editing technologies, provide opportunities to develop new fruit cultivars more rapidly. Our review, emphasizes the socioeconomic impact of current commercial fruit cultivars developed by genetic engineering and the potential impact of genome editing on the development of improved cultivars at an accelerated rate. Nature Publishing Group UK 2021-07-17 /pmc/articles/PMC8286259/ /pubmed/34274949 http://dx.doi.org/10.1038/s41438-021-00601-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Lobato-Gómez, Maria
Hewitt, Seanna
Capell, Teresa
Christou, Paul
Dhingra, Amit
Girón-Calva, Patricia Sarai
Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities
title Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities
title_full Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities
title_fullStr Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities
title_full_unstemmed Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities
title_short Transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities
title_sort transgenic and genome-edited fruits: background, constraints, benefits, and commercial opportunities
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286259/
https://www.ncbi.nlm.nih.gov/pubmed/34274949
http://dx.doi.org/10.1038/s41438-021-00601-3
work_keys_str_mv AT lobatogomezmaria transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities
AT hewittseanna transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities
AT capellteresa transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities
AT christoupaul transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities
AT dhingraamit transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities
AT gironcalvapatriciasarai transgenicandgenomeeditedfruitsbackgroundconstraintsbenefitsandcommercialopportunities